Ambrisentan Tablets and Nourianz
Determining the interaction of Ambrisentan Tablets and Nourianz and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Consumer information for this interaction is not currently available.MONITOR: Coadministration with istradefylline may increase the plasma concentrations of drugs that are substrates of the P-glycoprotein (P-gp) transporter. The proposed mechanism is inhibition of P-glycoprotein-mediated drug efflux by istradefylline. When a single dose of the P-gp probe substrate digoxin (0.4 mg) was administered with istradefylline (40 mg daily for 21 days), the Cmax and total systemic exposure (AUC(inf)) of digoxin was increased by 33% and 21%, respectively, when compared with digoxin alone. MANAGEMENT: Caution is advised when istradefylline is used concurrently with drugs that are known P-gp substrates, particularly those with a narrow therapeutic range. Dosage adjustments as well as clinical and laboratory monitoring may be appropriate for some drugs whenever istradefylline is added to or withdrawn from therapy. References "Product Information. Nourianz (istradefylline)." Kyowa Kirin, Inc, Bedminster, NJ.
Professional:MONITOR: Coadministration with istradefylline may increase the plasma concentrations of drugs that are substrates of the P-glycoprotein (P-gp) transporter. The proposed mechanism is inhibition of P-glycoprotein-mediated drug efflux by istradefylline. When a single dose of the P-gp probe substrate digoxin (0.4 mg) was administered with istradefylline (40 mg daily for 21 days), the Cmax and total systemic exposure (AUC(inf)) of digoxin was increased by 33% and 21%, respectively, when compared with digoxin alone.
MANAGEMENT: Caution is advised when istradefylline is used concurrently with drugs that are known P-gp substrates, particularly those with a narrow therapeutic range. Dosage adjustments as well as clinical and laboratory monitoring may be appropriate for some drugs whenever istradefylline is added to or withdrawn from therapy.
- "Product Information. Nourianz (istradefylline)." Kyowa Kirin, Inc, Bedminster, NJ.
Generic Name: ambrisentan
Brand name: Letairis
Synonyms: Ambrisentan
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ambrisentan Tablets-Nov-Onxol
- Ambrisentan Tablets-Novacort
- Ambrisentan Tablets-Novaferrum
- Ambrisentan Tablets-NovaFerrum 50
- Ambrisentan Tablets-NovaFerrum Pediatric Drops
- Ambrisentan Tablets-NovaFerrum Pediatric Multivitamins with Iron
- Nourianz-Amcinonide
- Nourianz-Amcinonide Cream and Ointment
- Nourianz-Amcinonide Lotion
- Nourianz-Amcinonide Ointment
- Nourianz-Amcinonide topical
- Nourianz-Amcinonide Topical application